Latest Cancer Research Stories
Face2Gene® is a search and reference tool powered by the Facial Dysmorphology Novel Analysis Technology NEW YORK, March 12, 2015 /PRNewswire/ -- FDNA, the pioneer
Co-development agreement, brokered by MaRS Innovation, to advance ultrasound chemotherapy monitoring technology as clinical tool TORONTO, March 12, 2015 /PRNewswire/ -
Deadliest Cancers Coalition Calls on Congress to provide A Meaningful Increase for the NCI in FY2016 WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ -- As budget discussions heat
SAN DIEGO, March 9, 2015 /PRNewswire/ -- Epic Sciences and The Prostate Cancer Clinical Trials Consortium (PCCTC), the leading consortium for Phase 1/2 and Phase 2 clinical trials in prostate
New Therapy Will Harness the Power of Patients' Own Immune Systems to Fight Lung Cancer WASHINGTON, March 5, 2015 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung
CALGARY, March 5, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
Conference Basketball Coaches to Kick-Start National Fundraising Initiative Cary, NC (PRWEB) March 02, 2015 The V Foundation for Cancer Research, one
WASHINGTON, March 2, 2015 /PRNewswire-USNewswire/ -- To kick off Women in History month, LUNGevity Foundation announces Dr.
"Knowledge is Power" Is Key Message of Month-Long Awareness Campaign NORTH HOLLYWOOD, Calif., March 2, 2015 /PRNewswire/ -- The International Myeloma Foundation (IMF), dedicated to
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
- Large; stout; burly.